- Home
- ARR vs ARQT Comparison
ARR vs ARQT Comparison
Compare ARR & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARR
- ARQT
- Stock Information
- Founded
- ARR 2008
- ARQT 2016
- Country
- ARR United States
- ARQT United States
- Employees
- ARR N/A
- ARQT N/A
- Industry
- ARR Real Estate Investment Trusts
- ARQT Biotechnology: Pharmaceutical Preparations
- Sector
- ARR Real Estate
- ARQT Health Care
- Exchange
- ARR Nasdaq
- ARQT Nasdaq
- Market Cap
- ARR 1.1B
- ARQT 1.1B
- IPO Year
- ARR N/A
- ARQT 2020
- Fundamental
- Price
- ARR $18.76
- ARQT $13.08
- Analyst Decision
- ARR Hold
- ARQT Strong Buy
- Analyst Count
- ARR 2
- ARQT 5
- Target Price
- ARR $21.00
- ARQT $17.00
- AVG Volume (30 Days)
- ARR 2.3M
- ARQT 2.0M
- Earning Date
- ARR 02-12-2025
- ARQT 02-25-2025
- Dividend Yield
- ARR 15.35%
- ARQT N/A
- EPS Growth
- ARR N/A
- ARQT N/A
- EPS
- ARR 2.41
- ARQT N/A
- Revenue
- ARR $185,086,000.00
- ARQT $138,708,000.00
- Revenue This Year
- ARR N/A
- ARQT $209.03
- Revenue Next Year
- ARR $295.11
- ARQT $49.00
- P/E Ratio
- ARR $7.81
- ARQT N/A
- Revenue Growth
- ARR N/A
- ARQT 182.84
- 52 Week Low
- ARR $17.35
- ARQT $3.59
- 52 Week High
- ARR $21.93
- ARQT $16.20
- Technical
- Relative Strength Index (RSI)
- ARR 49.17
- ARQT 46.24
- Support Level
- ARR $18.00
- ARQT $12.61
- Resistance Level
- ARR $18.38
- ARQT $14.36
- Average True Range (ATR)
- ARR 0.32
- ARQT 0.98
- MACD
- ARR -0.00
- ARQT -0.32
- Stochastic Oscillator
- ARR 53.19
- ARQT 13.09
About ARR ARMOUR Residential REIT Inc.
ARMOUR Residential REIT Inc is a real estate investment trust that invests in residential mortgage-backed securities or RMBS. These are issued or guaranteed by U.S.-government-sponsored enterprises, such as Fannie Mae, Freddie Mac, or Ginnie Mae. The company's investment portfolio is composed of mortgage-backed securities, adjustable-rate mortgage securities, and multifamily mortgage-backed securities. In terms of total fair value, most Armour's investments are long-term, fixed-rate agency RMBS. Multifamily RMBS also represents a substantial amount. Fannie Mae guarantees most of the company's holdings. Armour derives substantially all its revenue as interest income from its investments.
About ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's lead product candidate ZORYVE roflumilast cream, has successfully completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.